AI-Identified CD133-Targeting Natural Compounds Demonstrate Differential Anti-Tumor Effects and Mechanisms in Pan-cancer Models

ABSTRACT: Advanced algorithms have significantly improved the efficiency of in vitro screening for protein-interactive compounds. However, target antigen (TAA/TSA)-based drug discovery remains challenging, as predictions of compound-protein interaction (CPI) based solely on molecular structure fail to fully elucidate the underlying mechanisms. In this study, we utilized deep learning, specifically TransformerCPI to screen active molecules from a Chinese herb compound library based on protein sequences. Two natural products, Polyphyllin V and Polyphyllin H, were identified as targeting the pan-cancer marker CD133. Their anti-tumor efficacy and safety were confirmed across validation in cancer cell lines, tumor patient-drived organoids, and animal models. Despite their analogous structures and binding

SUBMITTER: Yibo Hou 

PROVIDER: S-SCDT-10_1038-S44321-025-00308-1 | biostudies-other |

REPOSITORIES: biostudies-other